NXTC · NASDAQ
NextCure (NXTC) Stock Price & Fundamentals
NextCure (NXTC) closed at $842.04 on Oct 9, 2026, up 1.78% from the previous close of $827.28.
Share price, past year
1Y +10.31%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $842.04 |
| Sep 30, 2026 | $833.60 |
| Aug 31, 2026 | $839.17 |
| Jul 31, 2026 | $814.80 |
| Jun 30, 2026 | $806.21 |
| May 29, 2026 | $790.65 |
| Apr 30, 2026 | $768.37 |
| Mar 31, 2026 | $750.20 |
| Feb 27, 2026 | $753.21 |
| Jan 30, 2026 | $758.15 |
| Dec 31, 2025 | $731.09 |
| Nov 28, 2025 | $748.71 |
| Oct 31, 2025 | $760.88 |
Key statistics
- Market cap
- $3.43B
- P/E (TTM)
- —
- EPS (TTM)
- −$8.33
- Revenue (TTM)
- —
- Net income (TTM)
- −$42.75M
- Shares outstanding
- 4.1M
- Dividend yield
- —
- 52-week range
- $728.22 – $851.40
NextCure's market cap is $3.43B, based on a share price of $842.04 and 4.1M shares outstanding as of Jun 30, 2026.
Financials
NextCure reported revenue of $22.38M for fiscal 2020, up 252.58% from fiscal 2019.
NextCure reported a net loss of $55.84M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2020ended Dec 31, 2020 | $22.38M | +252.6% | −$36.60M | −163.6% | −$1.33 | −$52.09M |
| FY2019ended Dec 31, 2019 | $6.35M | — | −$33.74M | −531.5% | −$2.15 | −$38.99M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q1 FY2020ended Mar 31, 2020 | $22.38M | — | — |
| Q4 FY2019ended Dec 31, 2019 | $2.01M | — | — |
| Q3 FY2019ended Sep 30, 2019 | $1.58M | — | — |
| Q2 FY2019ended Jun 30, 2019 | $1.40M | — | — |
| Q1 FY2019ended Mar 31, 2019 | $1.36M | — | — |
Company profile
- Name
- NextCure, Inc.
- Ticker
- NXTC
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 2850 Quarry Lake Drive, Suite 280, Baltimore, MD 21209
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001661059
Recent SEC filings
- Sep 25, 2026
- Sep 3, 2026
- Aug 6, 2026
- Aug 6, 2026
- Jul 14, 2026
- Jun 25, 2026
- Jun 1, 2026
- May 7, 2026
Frequently asked questions
What is NextCure's stock price?
NextCure (NXTC) closed at $842.04 on Oct 9, 2026, up 1.78% from the previous close of $827.28.
What is NextCure's market cap?
NextCure's market cap is $3.43B, based on a share price of $842.04 and 4.1M shares outstanding as of Jun 30, 2026.
How much revenue does NextCure make?
NextCure reported revenue of $22.38M for fiscal 2020, up 252.58% from fiscal 2019.
Does NextCure pay a dividend?
Yes. NextCure declared $0.00 per share in dividends for fiscal 2025.
Sources and methodology
Fundamentals come from NextCure, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures